Fate Therapeutics (FATE) Granted FDA Orphan Drug Status for ProTmune
Go back to Fate Therapeutics (FATE) Granted FDA Orphan Drug Status for ProTmune| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 5.64 -0.13 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.77 | 52 Week High | $4.76 | |||
| Open | $5.80 | 52 Week Low | $1.46 | |||
| Day High | $5.96 | P/E | N/A | |||
| Day Low | $5.39 | EPS | $-1.91 | |||
| Volume | 2,687,398 | |||||
